January 9, 2019   USA
J.P. Morgan Healthcare Conference Update
During the J.P. Morgan 37th Annual Healthcare Conference Diamyd Medical founder Anders Essen-Möller and CEO Ulf Hannelius met with the team behind the Bluetooth-connected insulin pen InPen, Companion Medical founders CEO Sean Saint and CTO Mike Mensinger.
Information presented here are not press releases and may include excerpts from and links to externally published content. Diamyd Medical is not responsible for externally published content.

Order GAD for preclinical research

GAD PRODUCTS